Behavioral
Structured Lifestyle Intervention
Structured Lifestyle Intervention is a behavioral intervention with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
40%
Ph not_applicable
3
60%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(2)
Detailed Status
Not yet recruiting2
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (40.0%)
N/A3 (60.0%)
Trials by Status
not_yet_recruiting240%
recruiting120%
completed240%
Recent Activity
1 active trials
Showing 5 of 5
completednot_applicable
The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study
NCT05007353
recruitingnot_applicable
Tirzepatide Impact Assessment Study
NCT07740291
not_yet_recruitingphase_4
Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients
NCT07715929
not_yet_recruitingphase_4
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
NCT07630454
completednot_applicable
U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk
NCT03688126
Clinical Trials (5)
Showing 5 of 5 trials
NCT05007353Not Applicable
The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study
NCT07740291Not Applicable
Tirzepatide Impact Assessment Study
NCT07715929Phase 4
Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients
NCT07630454Phase 4
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
NCT03688126Not Applicable
U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk
All 5 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 5